REN and Parkinson disease: Moreover, some antihypertensive medications may contribute to PD risk; inhibitors of the renin–angiotensin–aldosterone system may delay proinflammatory effects, and alpha-1-adrenergic receptor antagonists can enhance glycolysis and could reduce PD risk (82–87).